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Abstract. We report on the synthesis and characterization of porous monodisperse vaterite 
containers with controllable average sizes from 400 nm to 10 µm. Possible release strategies of 
enclosed substances via recrystallization or by pH-change are presented. As a model experiment, a 
fluorescent marker was encapsulated and imaged by two-photon microscopy to monitor the dye 
release. The release process was found to be controllable via the immersion medium’s properties. 
Release times can be further tuned by covering the containers with additional polymer layers, 
creating a flexible system with promising perspectives for pharmaceutical applications. 
Introduction 
Calcium carbonate as an inorganic biomaterial has attracted much attention in recent years owing to 
its advantages such as chemical stability, bioactivity, and biocompatibility [1, 2].  
It exists in three anhydrous polymorphic modifications: vaterite, aragonite, and calcite. At ambient 
temperature and atmospheric pressure, vaterite is a meta-stable phase, while calcite and aragonite 
are the stable [3]. Sub-micron containers of porous CaCO3 with high surface area are especially 
desirable to optimize cellular uptake and drug loading capacity. The fabrication of such particles has 
been a big challenge [4]. 
Their size and shape have a strong influence on their stability in solutions and on their 
recrystallization properties. An efficient way of controlling the size of spherical vaterite particles 
from 10 down to 0.4 microns has been reported very recently [5]. Apart from shrinking the size, an 
important issue in this system is the manipulation of the release dynamics. The two most common 
processes used for cargo release from porous carriers are desorption-adsorption [6–8] and, 
especially important for small containers, the dissolution of the carrier [9]. Anyway, both processes 
offer rather limited control of the release rate [6]. In more sophisticated applications, this may 
indeed become a problem since many target systems for drug delivery need spatial and temporal 
control of the cargo release.  
Here we report on a technique for sub-micron vaterite capsules for a delayed burst release of cargos, 
exploiting a crystal phase transition, which can be controlled by changing the properties of the 
surrounding solution. 
Materials and methods 
Particle synthesis. All chemicals were purchased from Sigma-Aldrich and used without further 
purification. For the preparation of sub-micron vaterite spheres, the protocol described in [5] was 
applied. CaCO3 precipitates, formed as a result of colloidal aggregation during rapid mixing of 
CaCl2 and Na2CO3 in aqueous solutions, were transformed into ordered spherulites. The chosen 
concentrations of CaCl2 and Na2CO3 were 0.33 M. Ethylene glycol (EG) was added to this reaction 
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 solution (Na2CO3 and CaCl2 were dissolved each in 2 ml water and 10 ml EG). The solution was 
stirred at 500 rpm at room temperature for 3 h. The synthesized CaCO3 particles were carefully 
washed with ethanol and dried for 1h at 60°C. 
Encapsulation and Release. For the encapsulation of Rhodamine 6G (Rh6G), 2 ml of a 1 mg/ml 
solution of the dye were added to 30mg dried vaterite containers. The uptake happened during 
30 min of shaking. After centrifuging with 3200×g for 3min, the remaining free dye molecules 
where washed off 3 times with ethanol. Finally, the sample was dried again for 3h at 60°C. The dry 
sub-micron containers could be stored for at least 30 days without any sign of degradation. Storage 
in ethanol gave equally good result. 
Spectrofluorimetry (Cary Eclipse, Varian) was used to measure the Rh6G uptake efficiency.  The 
total weight of particles was kept constant (7 mg) in all experiments. Some loss of capsules during 
the repeated washing steps may have occurred, but did not exceed a few percent. As a measure of 
the amount of Rh6G in solution, its fluorescence intensity was recorded at 555 nm. A calibration 
curve was obtained from fluorescence measurements of known concentrations of Rh6G. Then 
samples were diluted in water to ensure that measurements are within the linear range of the 
calibration curve. The total amount of encapsulated molecules was deduced subtracting the 
measured amount of unloaded and washed-off molecules from the initial amount of 0.015 mg Rh6G 
which had been added to the system.  
To investigate the release process, loaded microcapsules were resuspended in a certain volume of 
various liquids (pure water, ethanol, cell media, and physiological solution) and allowed to incubate 
at room temperature in carefully sealed centrifuge tubes. After different incubation times, the 
samples were centrifuged, then the concentration of dye in the supernatant was measured. 
To study the containers’ morphology, a field emission scanning electron microscope (XL 30, 
FEI-Philips) was used. The size distribution of the vaterite containers and the transition between the 
vaterite and the calcite phase were imaged with magnifications from 5000× to 50000×. Statistical 
image analysis was performed using ImageJ (NIH), based on N=100 particles per sample. 
The optical studies of the encapsulation and the release processes were performed using a two-
photon laser scanning microscope (2PM) (Ultima IV, Prairie Technologies) with a 100× objective 
(NA 1.0, water immersion, Olympus) and an ultra-short pulsed laser (Mai Tai Deep See HP, 
Spectra-Physics) as an excitation source at 840nm wavelength. Images were postprocessed using 
Matlab (Mathworks) and Amira (Visage imaging). 
Results and discussion 
Vaterite particles with an average size of 400nm were obtained as described above. The 
recrystallization process from the vaterite to the calcite phase during the immersion in water-based 
solutions was demonstrated by scanning electron microscopy.  
Fig. 1 presents the calcium carbonate particles in different phases during the recrystallization 
process: The initial state are pure vaterite particles (a), the recrystallization process starts when 
vaterite particle are put into a water-based solution. The external layer of vaterite starts to solvate 
and ionize, seeding the formation of calcite crystals from the ions. During this phase, a mix of both 
phases was observed (b). While after the completion of the recrystallization process only calcite 
crystals could be found (c). 
To investigate the behavior of an incorporated substance during this recrystallization process, a 
model experiment was performed, encapsulating a fluorescent marker and imaging it by two-photon 
microscopy and spectrofluorimetry, to monitor the dye release. The symbolic images in Fig. 1 show 
the dye encapsulation and release scheme based on the recrystallization process described before.  
 During the 1st days, only a small amount (about 6%) of the encapsulated dye was found in the 
solution which can be attributed to a desorption-adsorption process. Dye is slowly released and a 
dynamic equilibrium is obtained. Here the initial particle load influences the dye concentration in 
the solution.  During the 2nd and 3rd day, the recrystallization process sets in and the dye is quickly 
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 released from the containers during the phase transition, increasing the amount of particles in the 
solution. Up to 55% of the initially encapsulated dye was detected in the solution after the complete 
recrystallization of all vaterite particles at day 4. The residual dye remained attached to the calcite 
surface or within inter-particle gaps. 
 
 
 
 
Figure 1 Above) Schematics of the crystal phase transition in water from sub-micron vaterite 
particles to calcite monocrystals, inducing dye release during the recrystallization. Below) Scanning 
electron microscopy images of the calcium carbonate crystals in the different phases at different 
times: a) vaterite particles at the 1
st
 hour of immersion in water based solution, b) calcite and 
vaterite on the 2
nd
 day of immersion c) calcite crystals on the 4
th
 day after immersion.  
 
The dye release was analyzed by two photon microscopy. Fig. 2 presents a snapshot during the 
recrystallization process corresponding to the phase in Fig. 1b. The image series show a z-scan 
through the system with image planes at 2 µm distance. The bright fluorescent spheres at the bottom 
of the sample are the dye-loaded vaterite containers. Single calcite monocrystals appear as dark 
shadows. In the higher image planes the vaterite disappears and the bigger calcite crystals give 
evidence that the fluorescent marker was removed from their centers, their slightly fluorescing 
surfaces indicate some residual dye. The reconstructed volume image below visualizes these 
observations again in a 3D view. The non-fluorescing calcite crystals have been artificially 
highlighted in blue. The appearance of calcite monocrystals and the strong drop in fluorescence 
were found to be spatially and temporally correlated throughout all experiments, indicating that the 
dye release is driven by the recrystallization process.  
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Figure 2) 2PM images of the vaterite and calcite particles during the recrystallization process 
(corresponding to the situation in Fig. 1b). (a-c) An image stack with the focal plane being shifted 
upwards in steps of 2 micron. (d) Reconstructed volume image in a 3D view showing the brightly 
fluorescing vaterite containers (yellow) and the dark calcite crystals (highlighted in blue) 
 
This intrinsic release process has the further advantage to be controllable via the immersion 
medium (Table 1). After immersion in water for 90 hours, all vaterite particles had recrystallized to 
calcite. To inhibit recrystallization, containers can be immersed in pure ethanol, in this case only the 
slow dye desorption process was observed, leaving vaterite crystals intact. An acceleration of the 
recrystallization process instead was achieved by immersion in sodium chloride solution. For 0.9 
% (w/v) of NaCl corresponding to physiological solution, the time for complete recrystallization 
decreased to 61 hours.  
 
 
 
 
 
 
 
a) b) c) 
25µm 25µm 25µm 
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 Table 1) Result of the phase transition of vaterite particles during the immersion in different media 
Immersion solution Immersion time (hours)  
Crystalline phase at the end 
of the immersion time 
starting from 100% vaterite 
Physiological saline (0.9 % w/v of NaCl) 61 100% calcite  
Distilled water 90 100% calcite  
Pure ethanol 90 100% vaterite  
 
Another parameter to control the dye release is the solution’s pH. A change from neutral (pH=7) 
to acid (pH=5) conditions was found to cause a rapid dissolution of the vaterite matrix within 
seconds, followed by a burst-release of the encapsulated materials. 
For applications requiring further active control of the drug release, various coatings can be 
added to the vaterite containers, as shown in numerous works (for a review see Antipina and 
Sukhorukov [10]). Depending on the surface modifications, the release can then be triggered by 
changes of temperature [11, 12] or laser irradiation [13].  
The various flexible control mechanisms reported above, together with its simplicity and cost-
effectiveness make this system a promising candidate e.g. for drug delivery application.  
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